Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.8.0.1
Consolidated Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Revenues:    
Product revenues $ 7,024,010 $ 5,600,453
Service and other revenues 355,515 149,001
Total revenues 7,379,525 5,749,454
Cost of revenues 2,898,808 2,642,763
Research and development costs 2,813,733 2,628,179
Sales and marketing expenses 3,956,455 3,777,119
General and administrative expenses 4,046,366 4,190,131
Operating loss (6,335,837) (7,488,738)
Other income (expense):    
Gain on change in fair value of derivative liabilities 24,728 1,065,935
Loss on debt restructuring (811,909)
Other income, net 16,682 216,075
Interest expense, net (872,926) (1,051,258)
Net loss $ (7,167,353) $ (8,069,895)
Net loss per share attributable to common stockholders:    
Basic and diluted (in dollars per share) $ (0.93) $ (2.93)
Weighted average shares outstanding:    
Basic and diluted (in shares) 7,738,343 2,754,803